Status:
COMPLETED
A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)
Lead Sponsor:
Mati Therapeutics Inc.
Collaborating Sponsors:
QLT Inc.
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).
Eligibility Criteria
Inclusion
- Over 18 years
- Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension
Exclusion
- Uncontrolled medical conditions
- Subjects who wear contact lenses
- Subjects requiring chronic topical artificial tears, lubricants, and /or requiring any other chronic topical medications
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00821002
Start Date
January 1 2009
End Date
November 1 2009
Last Update
September 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menlo Park, California, United States, 94025